Evidence map›Paper›PMID 37195432›Full record

ArticleEuropean radiology2023

Safety and performance of MR-conditional pacing systems with automated MRI mode at 1.5 and 3 Tesla.

Jean-Nicolas Dacher, Patrick Langguth, David Adam, Walther-Benedikt Winkler, Julio Martí-Almor, Günther Prenner, María Emilce Trucco, Amir Kol, Meixiang Xiang, Donato Melissano and 2 more

Abstract read
In one paragraph

Article in European radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jean-Nicolas DacherDepartment of Radiology, Normandie Univ, UNIROUEN INSERM U1096 and CHU Rouen, 37 Boulevard Gambetta, 76000, Rouen, France. jean-nicolas.dacher@chu-rouen.fr.ORCID http://orcid.org/0000-0002-7681-5252
Patrick LangguthDepartment of Radiology and Neuroradiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
David AdamMonash Cardiac Rhythm Management Department, Monash Heart, Monash Medical Centre, Melbourne, Australia.
Walther-Benedikt WinklerMedical Department II With Cardiology and Intensive Care Medicine, Klinik Landstrasse, Vienna, Austria.
Julio Martí-AlmorDepartment of Cardiology, Hospital del Mar (IMAS-UAB), Barcelona, Spain.
Günther PrennerUniversitätsklinik Für Innere Medizin, Klinische Abteilung Für Kardiologie, Medizinische Universität Graz, Graz, Austria.
María Emilce TruccoArrhythmia Section, Cardiology Department, Hospital Universitari Doctor Josep Trueta, Girona, Spain.
Amir KolDepartment of Cardiology, San Camillo De Lellis Hospital, ASL Rieti, Rieti, Italy.
Meixiang XiangDepartment of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Donato MelissanoFrancesco Ferrari Hospital, Casarano, Italy.
Hanan FawazClinical Affairs, MicroPort CRM, Clamart, France.
Dennis H LauCentre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, SA, Australia.

Funding

MICROPORT CAPRI NCT03811691MICROPORT EUDAMED: CIV-19-04-027946
6 · The paper itself

Abstract

objectivesTo evaluate at 1.5 and 3 T MRI the safety and performance of trademarked ENO

methodsA total of 267 implanted patients underwent MRI examination (brain, cardiac, shoulder, cervical spine) at 1.5 (n = 126) or 3 T (n = 141). MRI-related device complications, lead electrical performances stability at 1-month post-MRI, proper functioning of the automated MRI mode and image quality were evaluated.

resultsFreedom from MRI-related complications at 1 month post-MRI was 100% in both 1.5 and 3 T arms (both p < 0.0001). The stability of pacing capture threshold was respectively at 1.5 and 3 T (atrial:: 98.9% (p = 0.001) and 100% (p < 0.0001); ventricular: both 100% (p < 0001)). The stability of sensing was respectively at 1.5 and 3 T (atrial: 100% (p = 0.0001) and 96.9% (p = 0.01); ventricular: 100% (p < 0.0001) and 99.1% (p = 0.0001)). All devices switched automatically to the programmed asynchronous mode in the MRI environment and to initially programmed mode after the MRI exam. While all MR examinations were assessed as interpretable, artifacts deteriorated a subset of examinations including mostly cardiac and shoulder ones.

conclusionThis study demonstrates the safety and electrical stability of ENO CLINICAL RELEVANCE STATEMENT: ENO KEY POINTS: • Patients implanted with an MRI conditional cardiac pacemaker can be safely scanned under 1.5 or 3 Tesla MRI with preserved interpretability. • Electrical parameters of the MRI conditional pacing system remain stable after a 1.5 or 3 Tesla MRI scan. • The automated MRI mode enabled the automatic switch to asynchronous mode in the MRI environment and to initial settings after the MRI scan in all patients.

Indexed as

Atrial FibrillationPacemaker, ArtificialEquipment SafetyHumansMagnetic Resonance ImagingProspective StudiesArtificialCardiac pacemakerMagnetic fieldsMagnetic resonance imaging

Identifiers

PMID37195432
PMCPMC10189234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.